Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: A cautionary tale

Blood

Volumn 125, Issue 23, 2015, Pages 3627-3636

  Wang, Yuhuan ^a   Hayes, Vincent ^a   Jarocha, Danuta ^a,b   Sim, Xiuli ^a,c   Harper, Dawn C ^a   Fuentes, Rudy ^a   Sullivan, Spencer K ^a   Gadue, Paul ^a,c   Chou, Stella T ^a,c   Torok Storb, Beverly J ^d   Marks, Michael S ^a,c   French, Deborah L ^a,c   Poncz, Mortimer ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; LIPOSOME; THROMBIN RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; EX VIVO STUDY; FETUS; HALF LIFE TIME; HUMAN; HUMAN CELL; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE LIFESPAN; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; ANIMAL; CELL LINE; MACROPHAGE; METABOLISM; PATHOLOGY; TRANSPLANTATION;

ANIMALS; BLOOD PLATELETS; CELL LINE; HUMANS; MACROPHAGES; MEGAKARYOCYTES; MICE; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; THROMBOPOIESIS;

EID: 84930644370     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-593053     Document Type: Article

References (55)

1. Ware J, Corken A, Khetpal R. Platelet function beyond hemostasis and thrombosis. Curr Opin Hematol. 2013;20(5):451-456.
2. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res. 2013;112(11):1506-1519.
3. Ho-Tin-Noé B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost. 2011;9(Suppl 1):56-65.
4. Weyrich AS, Zimmerman GA. Platelets in lung biology. Annu Rev Physiol. 2013;75:569-591.
5. Machlus KR, Italiano JE Jr. The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013;201(6):785-796.
6. Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26(6):720-731.
7. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007;317(5845):1767-1770.
8. Zhang L, Urtz N, Gaertner F, et al. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). Blood. 2013;122(5):791-802.
9. Zhang L, Orban M, Lorenz M, et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med. 2012;209(12):2165-2181.
10. Aschoff L. Ueber capillaire embolie von riesenkernhaltigen Zellen Virchow's Arch Path Anat. 1893;134:11.
11. Howell WH, Donahue DD. The production of blood platelets in the lungs. J Exp Med. 1937;65(2):177-203.
12. Kuter DJ. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008;(69):9-18.
13. Thiagarajan P, Afshar-Kharghan V. Platelet transfusion therapy. Hematol Oncol Clin North Am. 2013;27(3):629-643.
14. Takayama N, Nishimura S, Nakamura S, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med. 2010;207(13):2817-2830.
15. Takayama N, Eto K. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. Methods Mol Biol. 2012;788:205-217.
16. Nakamura S, Takayama N, Hirata S, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014;14(4):535-548.
17. Lu SJ, Li F, Yin H, et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res. 2011;21(3):530-545.
18. Feng Q, Shabrani N, Thon JN, et al. Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Rev. 2014;3(5):817-831.
19. Fuentes R, Wang Y, Hirsch J, et al. Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest. 2010;120(11):3917-3922.
20. Cortin V, Pineault N, Garnier A. Ex vivo megakaryocyte expansion and platelet production from human cord blood stem cells. Methods Mol Biol. 2009;482:109-126.
21. Chou ST, Opalinska JB, Yao Y, et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood. 2008;112(12):4503-4506.
22. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010;28(10):1728-1740.
23. Sullivan SK, Mills JA, Koukouritaki SB, et al. High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia. Blood. 2014;123(5):753-757.
24. Mills JA, Wang K, Paluru P, et al. Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood. 2013;122(12):2047-2051.
25. Lordier L, Bluteau D, Jalil A, et al. RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun. 2012;3:717.
26. Rauova L, Hirsch JD, Greene TK, et al. Monocyte-bound PF4 in the pathogenesis of heparininduced thrombocytopenia. Blood. 2010;116(23):5021-5031.
27. Kienast J, Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood. 1990;75(1):116-121.
28. Nieswandt B, Schulte V, Bergmeier W. Flow-cytometric analysis of mouse platelet function. Methods Mol Biol. 2004;272:255-268.
29. Hu Z, Yang YG. Full reconstitution of human platelets in humanized mice after macrophage depletion. Blood. 2012;120(8):1713-1716.
30. Meng R, Wu J, Harper DC, et al. Defective release of a granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models. Blood. 2015;125(10):1623-1632.
31. Basani RB, Zhu H, Thornton MA, et al. Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. Blood. 2009;113(4):902-910.
32. Boylan B, Berndt MC, Kahn ML, Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood. 2006;108(3):908-914.
33. Canals M, Olivares R, Rosenmann M. A radiographic method to estimate lung volume and its use in small mammals. Biol Res. 2005;38(1):41-47.
34. Economopoulos V, Noad JC, Krishnamoorthy S, Rutt BK, Foster PJ. Comparing the MRI appearance of the lymph nodes and spleen in wild-type and immuno-deficient mouse strains. PLoS ONE. 2011;6(11):e27508.
35. Schagatay E, Richardson MX, Lodin-Sundström A. Size matters: spleen and lung volumes predict performance in human apneic divers. Front Physiol. 2012;3:173.
36. Rowan RM, Fraser C, Gray JH, McDonald GA. The Coulter Counter Model S Plus - the shape of things to come. Clin Lab Haematol. 1979;1(1):29-40.
37. Eason CT, Pattison A, Howells DD, Mitcheson J, Bonner FW. Platelet population profiles: significance of species variation and drug-induced changes. J Appl Toxicol. 1986;6(6):437-441.
38. Weingand KW, Odioso LW, Dameron GW, Laytart MJ, Stitzel KA. Hematology analyzer comparison: Ortho ELT-8/ds vs. Baker 9000 for healthy dogs, mice,and rats. Vet Clin Pathol. 1992;21(1):10-14.
39. Thon JN, Montalvo A, Patel-Hett S, et al. Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol. 2010;191(4):861-874.
40. Thon JN, Macleod H, Begonja AJ, et al. Microtubule and cortical forces determine platelet size during vascular platelet production. Nat Commun. 2012;3:852.
41. Holme S, Heaton A, Konchuba A, Hartman P. Light scatter and total protein signal distribution of platelets by flow cytometry as parameters of size. J Lab Clin Med. 1988;112(2):223-231.
42. Joutsi-Korhonen L, Sainio S, Riikonen S, Javela K, Teramo K, Kekomäki R. Detection of reticulated platelets: estimating the degree of fluorescence of platelets stained with thiazole orange. Eur J Haematol. 2000;65(1):66-71.
43. rd ed. Waltham, MA: Academic Press; 2012:581-602.
44. Diquattro M, Gagliano F, Calabrò GM, et al. Relationships between platelet counts, platelet volumes and reticulated platelets in patients with ITP: evidence for significant platelet count inaccuracies with conventional instrument methods. Int J Lab Hematol. 2009;31(2):199-206.
45. Koh KR, Yamane T, Ohta K, Hino M, Takubo T, Tatsumi N. Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders. Eur J Haematol. 1999;63(5):295-301.
46. Nishikii H, Eto K, Tamura N, et al. Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med. 2008;205(8):1917-1927.
47. Sitaru AG, Holzhauer S, Speer CP, et al. Neonatal platelets from cord blood and peripheral blood. Platelets. 2005;16(3-4):203-210.
48. th International Platelet Symposium; April 3-6, 2014; Maále Hachamisha, Israel.
49. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98(2):254-258.
50. Lambert MP, Sullivan SK, Fuentes R, French DL, Poncz M. Challenges and promises for the development of donor-independent platelet transfusions. Blood. 2013;121(17):3319-3324.
51. Dunois-Lardé C, Capron C, Fichelson S, Bauer T, Cramer-Bordé E, Baruch D. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood. 2009;114(9):1875-1883.
52. Pallotta I, Lovett M, Kaplan DL, Balduini A. Three-dimensional system for the in vitro study of megakaryocytes and functional platelet production using silk-based vascular tubes. Tissue Eng Part C Methods. 2011;17(12):1223-1232.
53. Nakagawa Y, Nakamura S, Nakajima M, et al. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol. 2013;41(8):742-748.
54. Thon JN, Mazutis L, Wu S, et al. Platelet bioreactor-on-a-chip. Blood. 2014;124(12):1857-1867.
55. Di Buduo CA, Wray LS, Tozzi L, et al. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood. 2015;125(14):2254-2264.